comprehensive -WSS

comprehensive

author：fashion 2025-09-30 20:18:07 - browse：714

Under a microscope, human prostate cancer cells, colorized in blue, appear in an air bubble — coverage from STAT — Under a microscope, human prostate cancer cells, colorized in blue, appear in an air bubble. Adobe

An early-stage clinical trial of a radiopharmaceutical drug developed by Johnson & Johnson showed some signs of efficacy in prostate cancer patients, newly released data show, but four participants in the trial died.

The drug, JNJ-6420, is designed to treat metastatic castration-resistant prostate cancer by delivering radioactive isotopes directly to cancer cells. Interest in such radiopharmaceuticals has skyrocketed following the approval of Pluvicto, which also treats prostate cancer.

In the Phase 1 data reported ahead of the American Society of Clinical Oncology meeting next week, 18% of participants on a mid-level dose of Johnson & Johnson’s treatment had a complete or partial response. For comparison, approximately 29.8% of the subjects in a Phase 3 trial of Pluvicto responded to the treatment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Organ transplantation is at a crossroads. Major reform is needed

entertainment

WSS

Russian special forces kill a gunman who broke into a private house near Moscow

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Body of missing toddler recovered in Delaware River days after flood: Police

Medical devices makers are asking for forgiveness, not permission

Steward Health Care expansion into Malta flopped

leisure time

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

Hepatitis C has a cure — but many Americans still lack access to it

Body of missing toddler recovered in Delaware River days after flood: Police

Medicare proposal to cover medical devices draws a mixed reaction

White House launches permanent pandemic office

Medicare proposal to cover medical devices draws a mixed reaction

Erich Jarvis studies song birds to learn about human stuttering

Dobbs anniversary: the lost opportunity of abortion as health care

Review: 'Barbie' will hit you like a shot in the heart

Malaria cases in Florida and Texas: Here’s what you need to know

HIPAA doesn't protect reproductive records from prosecutors

hotspot

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

Body of missing toddler recovered in Delaware River days after flood: Police

This gene therapy has record $4.25 million price. It's saved children.

New rules on organ donation and transplantation 'will bring chaos'

CRISPR technology availability, affordability needs to be expanded

Steward Health Care expansion into Malta flopped

focus

explore

entertainment

focus